Pingping Li

277 West Yanta Road
Xi'an, 710061, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Retraction Note: Simvastatin and Atorvastatin inhibit DNA replication licensing factor MCM7 and effectively suppress RB-deficient tumors growth.

Retraction Note: Simvastatin and Atorvastatin inhibit DNA replication licensing factor MCM7 and effectively suppress RB-deficient tumors growth.

Journal: Cell death & disease

Published: November 27, 2025

Occult metastasis of hormone receptor-positive breast cancer to the ovary: A case report and literature review.

Occult metastasis of hormone receptor-positive breast cancer to the ovary: A case report and literature review.

Journal: Medicine

Published: May 21, 2025

Comprehensively identifying and validating the implications of NR5A1 and DHX37 variants for 46,XY disorders of sex development diagnosis.

Comprehensively identifying and validating the implications of NR5A1 and DHX37 variants for 46,XY disorders of sex development diagnosis.

Journal: BMC medical genomics

Published: March 21, 2025

Correction: Loss of LKB1 disrupts breast epithelial cell polarity and promotes breast cancer metastasis and invasion.

Correction: Loss of LKB1 disrupts breast epithelial cell polarity and promotes breast cancer metastasis and invasion.

Journal: Journal of experimental & clinical cancer research : CR

Published: February 23, 2025

LMAN2 Promotes Breast Cancer Tumorigenesis and Drug Resistance by Interacting With MAPK9 via Activation of the MAPK Pathway.

LMAN2 Promotes Breast Cancer Tumorigenesis and Drug Resistance by Interacting With MAPK9 via Activation of the MAPK Pathway.

Journal: Cancer medicine

Published: May 05, 2024

Chronic stress dysregulates the Hippo/YAP/14-3-3η pathway and induces mitochondrial damage in basolateral amygdala in a mouse model of depression.

Chronic stress dysregulates the Hippo/YAP/14-3-3η pathway and induces mitochondrial damage in basolateral amygdala in a mouse model of depression.

Journal: Theranostics

Published: November 28, 2023

Correction to: MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma.

Correction to: MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma.

Journal: Cell death & disease

Published: November 10, 2022

Novel pathogenic variants in the androgen receptor gene associated with androgen insensitivity syndrome identified through exome sequencing and in silico analysis.

Novel pathogenic variants in the androgen receptor gene associated with androgen insensitivity syndrome identified through exome sequencing and in silico analysis.

Journal: Gene

Published: September 29, 2022

Research on the cutoff tumor size of omitting radiotherapy for BCSS after breast conserving surgery in women aged 65 years or oder with low-risk invasive breast carcinoma: Results based on the SEER database.

Research on the cutoff tumor size of omitting radiotherapy for BCSS after breast conserving surgery in women aged 65 years or oder with low-risk invasive breast carcinoma: Results based on the SEER database.

Journal: Breast (Edinburgh, Scotland)

Published: September 24, 2021

DNA methylation of Hugl-2 is a prognostic biomarker in kidney renal clear cell carcinoma.

DNA methylation of Hugl-2 is a prognostic biomarker in kidney renal clear cell carcinoma.

Journal: Clinical and experimental pharmacology & physiology

Published: January 09, 2020

Cell Polarity Protein Pals1-Associated Tight Junction Expression Is a Favorable Prognostic Marker in Clear Cell Renal Cell Carcinoma.

Cell Polarity Protein Pals1-Associated Tight Junction Expression Is a Favorable Prognostic Marker in Clear Cell Renal Cell Carcinoma.

Journal: Frontiers in genetics

Published: December 06, 2019

Metformin suppresses proliferation and invasion of drug-resistant breast cancer cells by activation of the Hippo pathway.

Metformin suppresses proliferation and invasion of drug-resistant breast cancer cells by activation of the Hippo pathway.

Journal: Journal of cellular and molecular medicine

Published: October 14, 2019

Showing 1-12 of 29

Last Updated: 09/26/2026